ArticleCancer research2012

Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers codriven by mutant EGFR containing T790M and MET.

Lu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.